Background: Systematic reviews and meta-analyses that do not include unpublished data in their analyses may be prone to publication bias, which in some cases has been shown to have deleterious consequences on determining the efficacy of interventions.
Background
A systematic review is a form of research synthesis that brings together all available evidence using pre-determined methodologies to address a specific research question [1] . These reviews, when appropriate, may contain one or more meta-analyses whereby effect sizes from primary studies are combined statistically to produce a pooled effect estimate. For example, a recent systematic review of ten primary studies noted a twofold increase in perinatal depression in women with unexpected pregnancies [2] . Awareness of the association between depression and unplanned pregnancies can serve to lower clinical threshold for detection of depressive symptoms in new mothers, which can lead to timely and appropriate intervention. As such, systematic reviews and meta-analyses have the potential to ameliorate clinical practice and are of particular importance in a rapidly evolving specialty of pregnancy and childbirth.
While well-conducted systematic reviews are often considered the gold standard for determining care guidelines, they are susceptible to bias. One particular bias, known as publication bias, occurs when systematic reviews are comprised only of published studies with statistically significant outcomes. This bias likely misrepresents the true effectiveness of an intervention since only results showing significant differences are included. For instance, a study by Hart and colleagues [3] assessed systematic reviews and meta-analysis carried out on nine medications that were approved by the FDA in a single year: 2001. They found that when unpublished data were incorporated in these reviews, only 7 % of these meta-analyses predicted the drug in question to have
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BMC Research Notes *Correspondence: vadimyerokhin@gmail.com 1 Oklahoma State University Center for Health Sciences, 1111 W. 17th St., Tulsa, OK 74107, USA Full list of author information is available at the end of the article the same efficacy. In other words, over 90 % of the systematic reviews carried out to make clinical decisions on interventions were incorrect as a result of publication bias. Publication bias is a known problem in maternalfoetal medicine research [4] , and perinatology researchers should take precaution to limit this form of bias from systematic reviews. In a high pressure and high litigation field such as pregnancy and childbirth, where knowledge of the most current research advances is expected, the importance of highest quality evidence-based medicine cannot be overstated.
The primary means to limit publication bias is to use comprehensive and far-reaching search strategies to identify unpublished and non-significant data. While many data sources have been proposed, perhaps the most promising is to use clinical trials registries to locate unpublished trial data. These registries have been created across the globe, and the rate of clinical trial registrations is on the rise. For example, ClinicalTrials.gov received 206,176 registrations in 2015 alone [5] . In other words, this website receives 25 Despite the large number of registered clinical trials and strong recommendations from the Cochrane Collaboration to search trials registries for unpublished data, recent evidence suggests limited use of registries by systematic reviewers [6] [7] [8] [9] .
Here, we examine the prevalence of use of clinical trials registries searches by systematic reviewers in pregnancy and prenatal health journals. We also catalogue the specific registries searched and whether unpublished trial data were successfully found and/or incorporated into the systematic review findings. Finally, we examine the temporal trend of clinical trials registry searches over the past 8 years since passage of the FDA Amendments act mandated the registration of most clinical trials involving human patients prior to commencement.
Methods

Study design
This was a meta-epidemiologic systematic review, and thus registration with the international prospective register of systematic reviews (PROSPERO) did not apply. We identified the top 20 journals in the Pregnancy and Childbirth subspecialty of health and medical sciences using Google Scholar's h5-index, which rates journals based on their "visibility and influence" [10] . Briefly, h5-index is an alternative to the traditional rating of scientific journals based on their "impact factor", which takes into account the number of times an article is cited vs. the number of publication a journal produces [11] . The top 20 highest-rated journals in Pregnancy and Childbirth were searched for systematic reviews and meta-analyses published between January 1, 2007 and December 31, 2015. A search strategy was developed for high sensitivity and designed through collaboration with a National Institutes of Health medical librarian. The search was performed on December 29, 2015 and deployed as follows: (((((((((((((((((((((((("Archives of . A more detailed search string, formatted in accordance with guidelines described in the Cochrane Handbook of Systematic reviews is publically available online (see "Availability of data and materials" section).
Data extraction and training
Articles were retrieved using the search string above. Citations were imported and full text articles were retrieved using EndNote ™ (Version X7). Each article not retrieved using this method was manually obtained by the authors through the home institution's library subscriptions.
A training session was conducted during which a set of detailed steps for systematic data collection and analysis was explained and demonstrated to the team. The data of interest included the full names and abbreviations of each of the clinical trials registries. The methodology, which was based on searching each full text using the "Find" function, was verified against previously published data [9] and achieved 100 % accuracy, as compared to the original study.
Screening and outcome measures
The authors (VY and BC) screened the title and abstract of all retrieved articles (N = 372) to determine if the citation met the criteria of a systematic review or metaanalysis. For the citations that likely did not meet the criteria, or if it was unclear whether or not the criteria were met, the full text of the study in question was carefully reviewed. Any disagreements were settled through a discussion between the authors. An article was classified as a systematic review if it met previously established criterion; specifically, articles were included if (1) the authors provided clear inclusion/exclusion criteria for the selected studies and (2) the authors attempted to perform a comprehensive search of the available literature on a pre-determined topic. A more detailed discussion on what constitutes a systematic reviews or meta-analysis can be found in previously published work [1, 12, 13] .
Analogous to current publications on the topic [6, 8, 9] , we chose to limit our search to the 16 World Health Organization (WHO)-approved registries given the stringent requirements for clinical trial registration maintained by these registries. We also included ClinicalTrials.gov, as it appears to be the most frequently searched clinical trials registry [6, 9] . The methods sections and any supplementary materials of each of the studies mentioning these clinical trials registries were carefully reviewed by Yerokhin and Carr to determine if the registry was searched, if usable data were found, and if the data were used for analysis in the publication. Finally, we chose to exclude Cochrane Central Register of Controlled Trials (CENTRAL) [14] , as it is a collection of published clinical trials rather than a trials registry.
With help of medical librarians (JC and MF), we also checked whether or not applicable data were available on trials registry databases by searching for specific trials using the keywords provided by the systematic reviewers. This was accomplished by randomly choosing 26 systematic reviews and meta-analyses from our dataset of 297 studies (see below) included for analysis. Randomized selection was performed using the random number generator in Microsoft Excel. Two separate queries were deployed: one through clinicaltrials.gov and another through WHO-approved registries. The data were considered to be available, when a search query returned clinical trials with available data prior to publication of the review (e.g. if a review was published in 2014, only trials with data available on, or before, 2013 were considered applicable). This study's protocol and manuscript creation was carried out in accordance to all applicable Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) [15] guidelines.
Results
Our PubMed search yielded a total of 372 articles published between January 1, 2007 and December 31, 2015. Of these, 297 publications were included for analysis ( Fig. 1) . A total of 75 studies were excluded from analysis because they either did not meet the criteria of a systematic review, or performed a pooled analysis of primary data from disease-specific databases. The main, coded dataset is publically available online (see "Availability of data and materials" section).
Clinical trials registry search by journal
The frequency of clinical trials registry searches was determined for each publication within the corresponding journal. Systematic reviews and meta-analyses pub- (Fig. 2) .
Use of clinical trials registry data
We reviewed each study that searched any of the 17 clinical trials registries and determined if the study (1) found any applicable data and (2) used the data in their analysis. The findings are graphically represented in Table 1 . The full text of each article was reviewed to determine if the authors indicated finding applicable data or using it. If this information was not explicitly provided in the article, we reviewed the author's data tables (when available) and verified the included references to determine if any of the data used for analysis was retrieved from a clinical trials registry. A total of 12 studies [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] searched either ClinicalTrials.gov or the WHO-approved registries and one [22] of these reviews reported searches of both. Of these, two systematic reviews reported [16, 20] that applicable data were found, but neither of the systematic reviews used the data. Furthermore, 8 of the reviews did not clearly indicate whether or not data were found [17, 19, [21] [22] [23] [24] [25] [26] and it was not possible to determine whether or not the data were used in 1 of the reviews [22] . In each of these cases, the corresponding cells are marked "yellow". With the collected data in hand, two major questions remained unanswered for the majority of the articles: (1) if the authors searched clinical trials registry data, did they find any relevant data? and (2) if relevant data were found, did they include the data in their analysis? In an attempt to answer these questions, a contributing author (BC) contacted the corresponding authors of each of the publication included in Table 1 Full-text articles included after screening (n = 274)
Full-text articles excluded after detailed review (n = 75) 14 Criteria not met 5 Editorials 7 Primary studies 9 Protocols 40 Reviews
Total number studies included in analysis (n = 297)
Records requiring further review (n = 98)
Full-text articles included after detailed review (n = 23) one applicable trial was found on a clinical trials registry, the trial was at the recruiting stage and did not have data available. The remaining three authors stated that data from clinical trials registries was not included because it was already published and included in the analysis dataset, dataset was missing or no unpublished findings met their inclusion criteria.
Clinical trials registry search between 2007 and today
In 2006, the WHO established a set of 20 items that must be included for a clinical trial to register with the approved databases [28] . Among these items are requirements for submission of primary and key secondary trial outcomes. In an effort to make this data publically available, WHO also created the International Clinical Trials Registry Portal (ICTRP) [29] , which can be searched by systematic reviewers for unpublished data. Similarly, the United States passed the Food and Drug Amendments Act of 2007 (FDAA) [30] , setting a higher standard for clinical trial registration at ClinicalTrials.gov. To assess the effect these landmark decisions on use of clinical trials registries, we analysed the frequency with which these registries were searched by year. Interestingly, although there was an increase in systematic reviews and metaanalyses published since 2007, the proportion of these studies searching clinical trials registries did not appear to increase (Fig. 3) . Because of indexing delays of published articles by PubMed, only seven systematic reviews were retrieved from the year of 2015, which is likely an underrepresentation of the total number published that year. Hence, it is difficult to draw any reliable conclusions about the number of systematic reviews and meta-analyses searching clinical trials registries that year.
Potential data from clinical trials
As described above and discussed in further detail below, reliability of systematic reviews and meta-analyses in guiding clinical decision-making is dependent on retrieval of all applicable data. Studies published in other disciplines have previously shown that valuable unpublished data is available on clinical trials registries, providing support for the need to search clinical trials registries when designing and performing a systematic review [3, 8] . However, no study to date has attempted to determine the value of searching clinical trials registries in Pregnancy and Childbirth systematic reviews.
Although it was not a primary outcome of this study, we searched the availability of data from clinical trials for 26 randomly selected systematic reviews. Clinicaltrials.gov ( NCT00363038, NCT00706004, NCT00493012, NCT00198822, NCT01198574), with a total of 61,228 patients enrolled. Each of these trials contained data, which should have been considered for, and could have potentially been used in, the systematic review.
Discussion
The goal of this study was to determine the frequency of clinical trials registry searches of systematic reviews and meta-analyses published in the highest-ranking Pregnancy and Childbirth journals. Our findings indicate that clinical trials registries continue to be widely underused in this specialty. Systematic reviewers are not using registries as a means to limit publication bias.
Given the broad scope of disease processes and the delicacy with which many clinical decisions in maternity and foetal care must be approached, systematic reviews and meta-analyses play a particularly important role in this specialty. By assimilating the most relevant primary research, systematic reviews and meta-analyses in the Pregnancy and Childbirth literature can be a useful tool for choosing an intervention that prioritizes "practices that are effective and least invasive, with limited or no known harms whenever possible" [31] . A fitting example is demonstrated in a systematic review performed by the Cochrane Collaboration Pregnancy and Childbirth Group, who summarized clinical trials assessing administration of corticosteroids to women at risk for pre-term birth [32] . Today, this routine intervention reduces infant mortality by 30-50 %.
Published in 1989, the book "Effective Care in Pregnancy and Childbirth" [33] was monumental in 2009 BMC Pregnancy Childbirth [ 24] 2011 Arch Dis Child Fetal Neonatal Ed [23] 2012 Midwifery [ 22] 2013 BMC Pregnancy Childbirth [ 17] 2013 J Matern Fetal Neonatal Med [ 16] 2013 J Matern Fetal Neonatal Med [ 25] 2013 Paediatr Perinat Epidemiol [ 21] 2014 Am J Perinatol [ 26] 2014 Am J Perinatol [ 27] 2014 J Perinatol [ 18] 2015 Arch Dis Child Fetal Neonatal Ed increasing availability and awareness of randomized trial evidence to pregnancy and maternal care physicians around the world. Since then, evidence-based medicine has become increasingly important for clinicians practicing in these specialties. The first large study to reveal the extent to which systematic reviews and meta-analyses influence clinical care in maternal and foetal medicine was performed by Wilson and colleagues [34] in 2002. The authors measured improvement in compliance with evidence-based medical guidelines across hospitals in United Kingdom in areas involving tissue closure, corticosteroid use for women at risk of pre-term birth, antibiotic prophylaxis for Caesarean section, and approaches to complicated vaginal birth. The authors found that since 1988, there was an average increase in compliance of 72, 82, 77 and 56 %, respectively for these specialties. Today, the sheer volume of systematic reviews and meta-analyses published in the pregnancy and childbirth literature is remarkable. It is estimated that the majority (over 20 %) of all systematic reviews and metaanalyses present in medical literature are published in gynaecology, pregnancy and childbirth specialties [35] . Although these estimates are based on publications by the Cochrane Collaboration, others have also found that publications in obstetrics and gynaecology journals comprise a large portion of systematic reviews available [36] . As such, it should come as no surprise that systematic reviews and meta-analysis in Pregnancy and Childbirth have shaped essential clinical decisions, such as timing of corticosteroid administration for women at risk for preterm birth [32] , methods of labour induction [37] , approaches to intrapartum anaesthesia [38, 39] , interventions for postpartum complications [40] and more [41] [42] [43] [44] [45] . With increased availability and use of systematic reviews and meta-analyses in making clinical decisions, it is essential that the quality of these works be maintained at the highest level. The movement to standardize and improve the quality of systematic reviews and meta-analyses in the obstetric literature has gained momentum in the past decade, as evidenced by the growing collection of publications on the topic [46] [47] [48] [49] [50] . Although increased standardization of systematic reviews and meta-analyses in the medical literature [51] has been improved, one aspect-methods to limit publication bias-continues to lag behind [6, 7, 9, [52] [53] [54] .
As awareness of publication bias in systematic reviews increases [7, [55] [56] [57] [58] , we are only beginning to affirm the detrimental effects publication bias has on clinical practice [59] [60] [61] [62] [63] [64] . In fact, a statement released in January 2016 by the International Committee of Medical Journal Editors (ICMJE) justly noted that "there is an ethical obligation to responsibly share data generated by interventional clinical trials because participants put themselves at risk. " [65] . An increased number of studies are finding that This study has a number of limitations. For instance, we did not specifically examine the rates of trial registration by country or region. It is possible that registration rates differ between countries due to specific legislations. For example, passage of the FDA Amendments Act in the United States contributed to a sharp increase in trial registrations. In countries with no such legislation, trial registrations may be lower. The intent of our study was to examine rates of registry searching by systematic reviewers, and it is not known whether systematic reviewers from countries with such legislation in place would be more likely to search a clinical trials registry due to a greater awareness of their existence. This would be an interesting avenue for future research; however, such an investigation would be complicated by the number of international multi-center collaborations and the possibility for authors to register with a registry outside of their home country. Additionally, although it appears that for most of the studies clinical trials data was available, the actual inclusion criteria for the data from each trial would have been determined by the authors of the systematic review and hence, may not have been applicable to the study. Even so, none of the authors from the 26 randomly-selected reviews (see Table 2 ) reported searching or finding clinical trials data.
Finally, it is interesting to note that although we found that by searching clinical trials registries, over 50 % of systematic reviews could have obtained additional data, only a small fraction of the trials available on these registries reported the data, and could thus be used without the need to retrieve the data ( Table 2 ). As such, it is possible that majority of authors may be discouraged from searching clinical trials registries, since the yield of available data is very low. If the case is such, we continue to strongly encourage the authors to search clinical trials registries for two reasons: (1) if time and monetary resources are an obstacle, it is still possible to set a filter to search only for trials, which contain data, hence, little effort is required to retrieve available data from trials registries and (2) it is possible to contact the research coordinator (whose contact information should always be listed on the study page) to ask for the missing data. Nonetheless, this may be a source of hesitation for authors and should thus be addressed in future research in order to perform a cost-benefit analysis for searching and attempting to retrieve the missing data from the registered clinical trials. We also encourage systematic reviewers to include more descriptive statements when reporting their data sources. Specifically, when a systematic reviewer does not indicate the source of retrieved data (as found in 7 of the 12 reviews listed in Table 1 ), it's not possible to determine if the source of data was a clinical trials registry or a database of published works. One possible solution is to use the PRISMA guidelines for reporting of systematic reviews, which includes a template flow diagram [15] .
Conclusions
In conclusion, systematic reviewers in Pregnancy and Childbirth should search clinical trials registries to mitigate the implications of publication bias on the predicted efficacy of an intervention. Currently, the immediate consequences of publication bias on clinical decisionmaking in Pregnancy and Childbirth have yet to be fully understood. There is, however, increasing evidence that publication bias is present in the primary research [4] , as well as systematic reviews and meta-analyses [14, [46] [47] [48] [49] [50] within the specialty. To our knowledge, this is the first study to undertake an assessment of this magnitude on the topic of publication bias in systematic reviews and meta-analyses in Pregnancy and Childbirth literature.
